Ultrastaging and Low-Volume Metastatic Disease in Early-Stage Cervical Cancer: State of the Art.
- Published in:
- Lymphatics, 2024, v. 2, n. 4, p. 260, doi. 10.3390/lymphatics2040020
- By:
- Publication type:
- Article
Works matching IS 28133307 AND DT 2024 AND VI 2 AND IP 4
Results: 5
1
2
Management of Secondary Immunodeficiency Following T-Cell-Engaging Immunotherapeutic Agents in B-Cell Non-Hodgkin Lymphoma: Implications for Early-Line Treatment Strategies.
- Published in:
- Lymphatics, 2024, v. 2, n. 4, p. 244, doi. 10.3390/lymphatics2040019
- By:
- Publication type:
- Article
3
Endovascular and Percutaneous Lymphatic Interventions in Cancer Patients: A Review Article.
- Published in:
- Lymphatics, 2024, v. 2, n. 4, p. 228, doi. 10.3390/lymphatics2040018
- By:
- Publication type:
- Article
4
The Current State of Lymphedema Surgery.
- Published in:
- Lymphatics, 2024, v. 2, n. 4, p. 212, doi. 10.3390/lymphatics2040017
- By:
- Publication type:
- Article
5
Lymphovascular Tumoral Emboli in Inflammatory Breast Cancer Result from Haptotaxis-Mediated Encircling Lymphangiogenesis.
- Published in:
- Lymphatics, 2024, v. 2, n. 4, p. 195, doi. 10.3390/lymphatics2040016
- By:
- Publication type:
- Article